| Date | Title | Description |
| 10.05.2024 | Kexing Biopharm Facility Passes EU GMP Certification for Paclitaxel for Injection (Albumin Bound) | SHENZHEN, China, May 10, 2024 /PRNewswire/ -- On the evening of May 5, Kexing Biopharm (stock code: 688136) announced it had obtained a "Certificate of GMP Compliance of a Manufacturer" granted by the Norwegian Medical Products Ag... |
| 29.04.2024 | North Carolina's rich list includes Jim Goodnight and Tim Sweeney again | figcaption>span]:font-sans">
James Goodnight, co-founder and CEO of the Cary data analytics firm SAS, remains North Carolina's wealthiest resident, according to Forbes' recently released list of the world's billionaires.
The big ... |
| 23.04.2024 | AI-powered data management: Navigating data complexity in clinical trials | The data flood gates have opened wide for clinical trial research. In fact, the amount of data gathered may be more akin to a tsunami or a monsoon. For decades, researchers struggled with a lack of data available in clinical trials; however... |
| 18.04.2024 | Strategies for Biomarker-Driven Sub-population Optimization in Clinical Trials, Upcoming Webinar Hosted by Xtalks | www.iqvia.com/solutions/technologies/orchestrated-clinical-trials
In this free webinar, review and understand the transformative impact of a biomarker-driven approach to identify sub-populations in clinical trials. Attendees will discover h... |
| 11.04.2024 | Nuevocor Strengthens Leadership Team with Appointment of John Lee as Chief Medical Officer | SINGAPORE and PHILADELPHIA, April 11, 2024 /PRNewswire/ -- Nuevocor, a pre-clinical stage biotechnology company dedicated to developing novel medicines to treat cardiomyopathies with aberrant mechanobiology, today announces the appointment ... |
| 14.03.2024 | Global Medical Device Outsourcing Market Forecast 2024-2033 – Market Size, Drivers, Trends, And Competitors | Medical Device Outsourcing Global Market Report 2024 : Market Size, Trends, And Global Forecast 2024-2033
The Business Research Company's Medical Device Outsourcing Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2... |
| 12.03.2024 | Real World Evidence/RWE Solutions Market is growing at a CAGR of 13.8% from 2024 to 2030 by Exactitude Consultancy | Real World Evidence (RWE) Solutions market
The Exactitude Consultancy Real World Evidence/RWE Solutions Market Report – Size, Trends, and Forecast 2024-2030
The Real World Evidence (RWE) Solutions market is experiencing high demand due to i... |
| 11.03.2024 | Patient Recruitment and Retention Services Global Market Report 2024 | - |
| 07.03.2024 | Oncology-Based In-Vivo CRO Market Projected for Vigorous Growth, North America Leads Regional Shares | - |
| 06.03.2024 | Life Sciences Next Gen Customer Engagement Platform Market | Veeva, Pitcher, Exeevo, IQVIA, Salesforce, Trueblue, WhizAI, ACTO, Viseven, Aktana, Seismic, Allego, ODAIA, Bigtincan, and Tellius, among others are some of the key players operating in the global market.
According to a new market research ... |
| 01.12.2023 | Biocon Biologics Successfully Completes Integration of Viatris' Biosimilar Business in 31 Countries in Europe | BENGALURU, India, Dec. 1, 2023 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the integration of the Viatris' biosimilars business in 31 European countries has be... |
| 21.11.2023 | Filling 12-month prescriptions is one practical way to help the pharmacist crisis | Pharmacies could be called the most “rock solid” entity in our health care system. Even before Covid, pharmacies were held in high esteem; during the pandemic, they raised their game by making it easy for tens of millions of Americans to ge... |
| 26.09.2023 | The problem with potential changes to the biosimilar regulatory framework | Biosimilars are no longer a new and untested class of medicines. Today, they provide critical treatment options across multiple therapeutic areas. Since the Biologics Price Competition and Innovation Act of 2009 created a regulatory pathway... |
| 01.09.2023 | The Self-Driving Clinical Trial: Optimizing Research with AI and ML | The power and potential of artificial intelligence (AI) and machine learning (ML) in the healthcare industry are unparalleled. The use of automated technology systems like digital workflows, orchestration and storing of data digitally is he... |
| 28.08.2023 | What do new weight loss drugs mean for the future of bariatric surgery? | Over the past year, weight loss drugs have captured the public’s imagination but also raised existential questions about the future of bariatric surgery.
For obesity, surgery has long been — and continues to be — the most effective treatmen... |
| 12.07.2023 | IQVIA’s SmartSolve® eQMS Named “Best New Technology Solution for Drug Development” in 2023 MedTech Breakthrough Awards Program | IQVIA Wins 2023 MedTech Breakthrough Award “SmartSolve enables organizations to drive continuous improvement in quality across global operations, and increase focus on ‘go-to-market, grow-in-market, stay-in-market’ organizational priorities... |
| 27.06.2023 | IQVIA Launches RIM Smart Labeling to Deliver Intelligence-Driven Approach for Global Label Management | IQVIA announced the launch of IQVIA RIM Smart Labeling, a comprehensive labeling solution for the life sciences industry that provides an intelligence-driven approach for more efficient and compliant global label management. Through this un... |
| 09.05.2023 | The IRA’s nonsensical distinction between small- and large-molecule drugs | Thanks to advances in science, notably the completion of the Human Genome Project 20 years ago, we are able to treat diseases more effectively than ever before. Researchers have more sophisticated tools not only to identify new drug targets... |
| 14.04.2023 | I’m a biopharma supply chain specialist — and even I can’t find the Adderall I’m prescribed | For 10 years, I have depended on Adderall to help me function. But in February, for the first time, the pharmacy down the street was unable to fill my prescription. In fact, 19 pharmacies in a row told me that they were out of stock. Thankf... |
| 27.02.2023 | IFPW Launches Environmental, Social, and Corporate Governance (ESG) Framework as a Pharmaceutical Industry Resource | The global pharmaceutical wholesalers' association has developed a collaborative framework to help organizations navigate ESG topics and share best practices.
MANASSAS, VIRGINIA, UNITED STATES, February 27, 2023 /EINPresswire.com/ -- The In... |
| 20.02.2023 | 5 Components of a Patient-Centric eCOA Strategy for Oncology Clinical Trials | Melissa Mooney, Director of eCOA Solutions Engineering at IQVIA
In the US alone, an estimated 1.9 million new cases of cancer were diagnosed in 2022, positioning oncology as a key subject of clinical research. Throughout oncology trial deve... |
| 31.01.2023 | IQVIA in Collaboration with Alibaba Cloud to Deliver Commercial & Clinical Solutions | Leading technology providers come together to bring innovative solutions addressing the unique business and compliance needs of the Greater China Region
IQVIA, a leading global provider of advanced analytics, technology solutions and clinic... |
| 09.12.2022 | FDA Accepts Biogen Biologics License Application for BIIB800, A Biosimilar Candidate Referencing ACTEMRA® (tocilizumab) | /EIN News/ -- CAMBRIDGE, Mass., Dec. 09, 2022 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) – announced that the U.S. Food and Drug Administration (FDA) has accepted for review the abbreviated Biologics License Application (aBLA) for BIIB8... |
| 23.09.2022 | Market share isn’t the only metric for biosimilars’ success | Market share is often held up as the most relevant metric for the success of a biosimilar class. I believe there are other metrics, like cost savings or signs of greater patient access, that should also be used to define biosimilars’ succes... |
| 23.09.2022 | Lyfegen raises $8M for its value-based drug contracting platform | Specialty medication prices in the U.S. are out of control. Despite making up about 2% of overall prescription volume, specialty drugs accounted for 53% of total annual pharmacy spending last year — up from 27% in 2010 — caused in part by g... |
| 21.09.2022 | Lyfegen secures $8 million to drive down drug costs | |
| 21.09.2022 | Humanizing the digital experience in healthcare | Ask any person to describe their experience with digital healthcare technology and they are likely to use adjectives such as complicated, frustrating and impersonal. The current tangle of electronic health systems, siloed point solutions an... |
| 20.09.2022 | Lyfegen Raises $8M for Value-Based Contracting for High-Cost Drugs | What You Should Know:
Currently, less than 2% of the health insurance population requiring specialty drugs is responsible for 51% of drug spending. The cost of specialty drugs in the US is spiraling out of control, increasing 12% from 2020 ... |
| 15.08.2022 | Connected Devices Selection: Considerations for A Digital-First Approach to Data Collection
| Mark Mentzer, Senior Director, Business Development, Connected Devices and eCOA, IQVIA
In recent years, digital health technologies (DHTs) have significantly changed the way we collect data within clinical trials. This is partially due to t... |
| 09.08.2022 | Here’s who Democrats’ drug pricing bill will actually help | WASHINGTON — Millions of patients in the Medicare program could eventually see lower prescription drug costs if Democrats pass their latest drug pricing plan into law.
The plan, which cleared a major hurdle Sunday when the Senate very narro... |
| 04.08.2022 | The outsized effect of ‘modest’ price controls on pharmaceutical innovation | Drug price controls in the U.S. Senate are being met with dire warnings that such an approach will stifle innovation, shut off the pipeline of new medicines, and cost lives down the road. Is innovation so fragile that a modest reduction in ... |
| 30.06.2022 | PBMs are inflating the cost of generic drugs. They must be reined in | These are not comfortable days in Washington for pharmacy benefit managers, the highly consolidated group of intermediaries that sit astride the drug supply chain. The Federal Trade Commission and Capitol Hill want to know how the PBMs’ arc... |
| 29.06.2022 | Reimagining The Future of Pharmacovigilance (PV): Regulations, Tech, Public Perceptions | Barry Mulchrone, Senior Director& Head of Pharmacovigilance Oversight and Analytics, IQVIAAnnette Williams, VP & Global Head, Lifecycle Safety, IQVIA
Monitoring the safe and effective use of medicines has now been an essential part ... |
| 19.05.2022 | ePROs: Better Patient Input for Better Trial Output | Kris Gustafson, Vice President and Global Head Patient Centered Technologies, IQVIA
During the pandemic, electronic clinical outcomes assessments (eCOAs) gained prominence as sponsors looked for more agile tools to help them capture patient... |
| 13.05.2022 | Avanos Medical Recalls Cortrak*2 Enteral Access System for Risk of Misplaced Enteral Tubes Could Cause Patient Harm | The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death. Recalled Product
Product Name: Avanos Medical Cortrak*2 Enteral Access System
Product Codes and Seri... |
| 11.05.2022 | How Web3 and Cloud3 will power collaborative problem-solving and a stronger workforce | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
The onset of the COVID-19 pandemic propelled clou... |
| 05.05.2022 | TIKOMED and IQVIA announce a strategic collaboration for the development of TIKOMED’s lead drug platform candidate ILB® | TIKOMED and IQVIA announce a strategic collaboration for the development of TIKOMED’s lead drug platform candidate ILB®
Thu, May 05, 2022 10:00 CET Report this content
Viken – 5th May, 2022 – Today, Swedish biopharmaceutical company TikoMed... |
| 26.04.2022 | Virgin Pulse Adds New Partners and Expanded Offerings to VP+ Program, Providing More Options for Addressing Health and Wellbeing Needs via Homebase for Health® | PROVIDENCE, R.I., April 26, 2022 (GLOBE NEWSWIRE) -- Virgin Pulse, the leading global digital-first health and wellbeing company, today announced the addition of five new or expanded partners to its VP+ partner program to provide more acces... |
| 13.04.2022 | Incentives to spur repurposing of existing generics for novel uses would open a new paradigm in drug R&D | The Drug Price Competition and Patent Term Restoration Act of 1984, better known as the Hatch-Waxman Act, which enabled the regulatory process for generic drugs, has been remarkably successful. Generic drugs now represent about 90% of presc... |
| 12.04.2022 | Thousands of layoffs planned as part of Novartis restructuring — report | Gilead can breathe a sigh of relief as the FDA lifts a partial hold on the “breakthrough” CD47 drug magrolimab — although the company is not quite off the hook yet.
After reviewing “comprehensive safety data,” regulators have removed the pa... |
| 12.04.2022 | Thousands of layoffs planned as part of Novartis restructuring — report | Novartis’ sweeping restructuring will reportedly lead to thousands of job cuts worldwide, including a “three-digit number” in its home of Switzerland.
UPDATED: Novartis CEO Vas Narasimhan restructures the pharma gian... |
| 12.04.2022 | Thousands of layoffs planned as part of Novartis restructuring — report | Johnson & Johnson’s Janssen is pointing in a positive, new direction for its Crohn’s disease and ulcerative colitis brand Stelara.
The new campaign called “UnstoppaBOLD” is purposeful in encouraging patients to get back to their “authen... |
| 11.04.2022 | Pharma firms make new pledge to launch in all Euro markets at least 2 years post-authorization | As part of a drive to increase new meds across Europe, member companies of the continent’s largest pharma lobbying organization have set a new goal to seek pricing and reimbursement in all EU countries no later than 2 y... |
| 11.04.2022 | Hours after Pfizer, Moderna names its own new CFO with dental, healthcare and auto chops | Roughly two hours after Pfizer named its new CFO, its Covid-19 vaccine competitor Moderna chalked up its own new CFO with a résumé steeped in healthcare, dental equipment and auto manufacturing.
Moderna’s current CFO, Da... |
| 11.04.2022 | Covid-19 roundup: Gavi raises $4.8B in pledged funds; Japan cancels order of 40M remaining AstraZeneca shots | Now roughly two years into the Covax initiative, the global vaccine alliance group Gavi has been trying to raise new money — and now has received pledges of $4.8 billion in funding.
The promised investment was announced on ... |
| 11.04.2022 | BioNTech to explore potential of delivering mRNA vaccines orally with new partner | After a Covid-19 vaccine success with partner Pfizer, and as the rest of its mRNA pipeline starts churning out data, BioNTech wants to go another delivery route with its jabs: orally.
The German biotech is paying an undiscl... |
| 11.04.2022 | Vanda takes FDA to court again, this time seeking more info on a rejection letter | After a previous court loss to FDA in early 2020 over a clinical hold, Vanda Pharmaceuticals returned to sue the agency again last week in the same DC district court, alleging this time that the agency is wrongfully withho... |
| 11.04.2022 | Merck extends pact with NK cell specialists at Artiva; Regeneron-allied biotech pencils in $15M IPO | More than a year into its discovery pact with the NK cell specialists at Artiva, Merck is apparently happy with what it’s seen so far.
So happy, in fact, that it wants to try new things with the platform.
The pharma giant has... |
| 11.04.2022 | Ballooning 340B market reaches almost 15% of 2021 US pharma sales, IQVIA finds | The tale of a booming federal drug discount program, which pharma companies have sought to curtail, has often been told but rarely with new numbers.
Now, the drug pricing gurus at IQVIA say their latest data shows that the pr... |
| 23.03.2022 | Как мобильные приложения помогают бороться с хроническими заболеваниями | Согласно отчету IQVIA Institute, в 2017 году существовало 318,5 тысяч медицинских мобильных приложений, и их количество увеличивалось на 200 ежедневно. 40% из них предназначены для пользователей с самыми разными заболеваниями — от диабета и... |
| 18.03.2022 | If pharma can market to youths by TikTok, it should include them in clinical trials | The pharmaceutical industry has rapidly adapted to promoting prescription drugs to young people on TikTok, Instagram, and other social media platforms, yet it can’t be troubled to include adolescents and young adults in clinical trials for ... |
| 10.02.2022 | Slovenian healthtech app Mediately raises €7.2M to make medical knowledge accessible across Europe | Ljubljana, Slovenia ~
Company:
Mediately, the Slovenian mobile and web app that makes drug information accessible to doctors, has just raised €7.2M in Series A to expand across more European markets. The round is led by the London-based Pit... |
| 07.01.2022 | 2022 predictions: Simpler, trusted health intelligence sharing | We all know some of the complexity in healthcare is unavoidable. It takes a wide range of organizations to ensure patients are cared for, and it’s no small task to understand their needs and balance their interests. But the last two years h... |
| 31.12.2021 | How Northwestern’s Catalyst Lab scales healthy behavior program with Couchbase | Hear from CIOs, CTOs, and other C-level and senior execs on data and AI strategies at the Future of Work Summit this January 12, 2022. Learn more
There’s no shortage of digital health apps on the market — more than 350,000, in fact, accordi... |
| 31.12.2021 | How Northwestern’s Catalyst Lab scales healthy behavior program with Couchbase | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
There’s no shortage of digital health apps on the... |
| 27.12.2021 | Хорошо жить долго: ученые и биохакеры в поисках «таблетки молодости» | Биохакер Дэйв Эспри, тот самый, который изобрел «пуленепробиваемый кофе» с маслом, мечтает дожить до 180 лет. Пионер в области облачных вычислений, как и многие другие обитатели Кремниевой долины, занимается проблемой долголетия всерьез. Би... |
| 15.12.2021 | SOFTWARE AS A MEDICAL DEVICE (SaMD). Часть 2: платформы, меняющие облик индустрии цифрового здравоохранения | SOFTWARE AS A MEDICAL DEVICE (SaMD). Часть 2: платформы, меняющие облик индустрии цифрового здравоохранения |
| 02.12.2021 | IQVIA Recognized As A Leader In BPO Solutions For Pharmaceutical Sales And Marketing | IQVIA recognized in IDC MarketScape for its data and analytics capabilities and growing suite of software platforms
IQVIA a leading global provider of advanced analytics, technology solutions, and clinical research services to the life scie... |
| 02.12.2021 | Omnicell : to Acquire ReCept - Form 8-K | Omnicell to Acquire ReCept
Strategic acquisition of leading specialty pharmacy management services provider supports the Autonomous Pharmacy vision and expands Omnicell's Advanced Services portfolio
Addresses significant need for access to ... |
| 06.11.2021 | The hurried push by Congress to address drug costs shouldn’t undermine the vast savings from generics and biosimilars | Americans rightfully expect Congress to address the ever-increasing prices of brand-name prescription drugs. But the wholesale policy changes now under rushed consideration in Congress will undermine the only proven solution to this long-st... |
| 04.11.2021 | Virgin Pulse Adds 7 Partners to Homebase for Health®, Expanding Global Options for Addressing Top Corporate Health and Wellbeing Concerns | Integrated Partner Ecosystem and Solutions Unlock Value of Health and Wellbeing Investments
PROVIDENCE, R.I., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Virgin Pulse, the leading global provider of tech-enabled solutions focused on improving the hea... |
| 04.11.2021 | Virgin Pulse Adds 7 Partners to Homebase for Health®, Expanding Global Options for Addressing Top Corporate Health and Wellbeing Concerns | Integrated Partner Ecosystem and Solutions Unlock Value of Health and Wellbeing Investments
PROVIDENCE, R.I., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Virgin Pulse, the leading global provider of tech-enabled solutions focused on improving the hea... |
| 04.11.2021 | Is the U.S. at a tipping point with biosimilars? | Is the U.S. at a tipping point with biosimilars?
11/04/2021
By Heidi Hunter, President, Cardinal Health Specialty Solutions at Cardinal Health
This week marks Global Biosimilars Week - a time when healthcare stakeholders around the world ar... |
| 21.10.2021 | IQVIA : Reports Third-Quarter 2021 Results and Raises Full-Year 2021 Guidance - Form 8-K | IQVIA Reports Third-Quarter 2021 Results and Raises Full-Year 2021 Guidance
Revenue of $3,391 million for the third quarter grew 21.7 percent year-over-year
GAAP Net Income of $261 million for the third quarter grew 158.4 percent year-over-... |
| 08.10.2021 | Biosimilars competition helps patients more than generic competition | Much of the current drug-pricing agenda proposed by President Biden and by Congress is based on the belief that greater government control — rather than free market competition — is the best way to lower drug prices. This view that competit... |
| 24.09.2021 | This Entrepreneur Proved That Startups Can Reinvent Themselves When Necessary | Chris Riley, Co-founder of USA RxChris Riley |
| 20.09.2021 | Health apps have to publicize data breaches, but that won’t stymie consumer uptake | The news: The FTC agreed on a policy requiring app makers capturing sensitive consumer data and health records to inform the FTC, US consumers, and in some cases, the media in the event of any security breaches.
Failure to comply could resu... |
| 01.09.2021 | IQVIA Launches New AI-Powered MI Contact Center For Life Sciences | IQVIA, a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, announced it has added new AI-powered technologies to enhance its existing Medical Information (MI) Contact ... |
| 05.08.2021 | Over 350K digital health apps are flooding the market—here’s how apps can stand out | The data: As the digital health market matures, it’s being inundated with health apps.
More than 90,000 health apps were released last year—an average of 250 being released per day, according to IQVIA’s new Digital Health Trends 2021 report... |
| 03.08.2021 | Report: Digital health tools maturing as research, funding grows | As investors pour record amounts of funding into digital health companies, consumers and benefits managers have a growing number of apps to evaluate. A new report by the IQVIA Institute for Human Data Science puts this into numbers.
The rep... |
| 03.08.2021 | IQVIA : United Nations Global Compact Communication | 3 August 2021
IQVIA's 2021 United Nations Global Compact Communication on Progress
IQVIA became a member of the United Nations Global Compact with effect from 31 July 2020. I am pleased to confirm that IQVIA reaffirms its support of the Ten... |
| 28.07.2021 | Amwell heats up the telehealth space with two new acquisitions | The news: Telehealth giant Amwell is acquiring digital mental health platform SilverCloud Health and automated virtual healthcare company Conversa Health for a combined $320 million. This comes around 10 months after Amwell was first mullin... |
| 27.07.2021 | IQVIA : Reports Second-Quarter 2021 Results and Raises Full-Year 2021 Guidance (Form 8-K) | IQVIA Reports Second-Quarter 2021 Results and Raises Full-Year 2021 Guidance
Revenue of $3,438 million for the second quarter grew 36.4 percent year-over-year
GAAP Net Income of $175 million for the second quarter increased from $(23) milli... |
| 08.07.2021 | DocuSign : Contract Management Solutions for Life Science Organizations | Life sciences organizations process a high volume and wide variety of contracts related to the commercialization of drugs and devices, as well as service agreements to maintain larger medical equipment. This contract process, including gene... |
| 30.06.2021 | Copay assistance should count as part of patients’ cost sharing for medications | The Biden administration has made health equity a priority and it has been a constant theme of conversation on Capitol Hill. But where do we go from here? One place is stopping health insurance companies and pharmacy benefit managers from p... |
| 16.06.2021 | The Evolving Landscape Of Funding And Investing In Biotech Startups | CEO of Bioverge, Inc., an investment platform that funds visionary entrepreneurs to bring science fiction to life. |
| 17.05.2021 | NOVARTIS AG
Press Release: Novartis: US Supreme Court denies Sandoz petition to review biosimilar Erelzi(R) (etanercept-szzs) case | -- Decision not to review Federal Circuit July 2020 ruling continues to prevent Sandoz launch of more affordable Erelzi treatment option for US patients -- Sandoz is disappointed US patients affected by chronic autoimmune and inflammatory d... |
| 17.05.2021 | US Supreme Court denies Sandoz petition to review biosimilar Erelzi® (etanercept-szzs) case | Decision not to review Federal Circuit July 2020 ruling continues to prevent Sandoz launch of more affordable Erelzi treatment option for US patients
Sandoz is disappointed US patients affected by chronic autoimmune and inflammatory disease... |
| 21.04.2021 | FDA: make medical apps reliable, not risky | The fear of Covid-19 catapulted symptom checkers from the periphery of public attention to the center. Wearables like the Apple Watch, Fitbit, and Oura Ring have shown promise as Covid-19 early-warning systems, while apps like MyCovidRisk l... |
| 31.03.2021 | Decentralized clinical trials are opening the drug development pipeline | There is no doubt that the Covid-19 pandemic has had a major impact on life sciences. Not only has it pushed the limits of modern medicine, but it has also created a significant backlog for clinical trials as well. More than 1,000 clinical ... |
| 02.03.2021 | ROYAL DSM N.V.
Royal DSM N : Integrated Annual Report 2020 | Royal DSM Integrated Annual Report 2020
Creating brighter lives for all
Table of contents
Key data
Co-CEO letter
Our approach to the Sustainable DevelopmentGoals
34
Statements of the Managing Board 144
Report by the Supervisory Board 145
Su... |
| 13.02.2021 | Another Keytruda combo tops standard of care in advanced kidney cancer, posing new test for Bristol's I/O med | In a new report out looking over the landscape of drug R&D, IQVIA has been tracking the swelling role that startups play in the development game. And some of the conclusions may surprise you.
First and foremost, the number of active R&a... |
| 03.02.2021 | Royal DSM N : Integrated Annual Report 2020 | Royal DSM Integrated Annual Report 2020
Creating brighter lives for all
Table of contents
Key data
Co-CEO letter
Our approach to the Sustainable DevelopmentGoals
34
Statements of the Managing Board 144
Report by the Supervisory Board 145
Su... |
| 12.01.2021 | What Could A Healthcare Marketplace Look Like? GoodRx Is Trying To Show Us | GoodRx qualified as a unicorn prior to its IPO, but its story and ambition is rare enough that it may warrant a new mythological creature dedication. Founded in 2011, the nine year-old digital health company went public last September with ... |
| 16.12.2020 | Unaffordable prescription drugs: the real legacy of the Hatch-Waxman Act | How is it possible to have a prescription drug price crisis when 90% of prescriptions are filled with generic drugs that cost, on average, $1 a day? The answer: The remaining 10% of prescriptions have an average cost of $20 a day and accoun... |
| 29.11.2020 | CIOs: With Vaccines On The Horizon, It’s Time To Accelerate | F1 drivers follow their racing lines through the challenging Eau Rouge turn in the Grand Prix of ... [+] Belgium.Getty Images |
| 13.11.2020 | The ‘prescription escalator’ may be to blame for rising out-of-pocket drug spending | A lot of attention and a bevy of proposals have focused on the rising cost of drugs, among all Americans, including older adults covered by Medicare.
But are these costs really rising as fast as people think? Or is the concern over drug spe... |
| 05.11.2020 | People With Silly Patents Would Really Like It If It Was Harder To Cancel Them | A large group of patent holders sent a letter to Congress expressing concern that, since the US Patent and Trademark Office (USPTO) Director Iancu might soon be leaving, recent policies making it harder to challenge bad patents might be rev... |
| 30.10.2020 | IQVIA Killing It In The Drug Trials Business | Imagine a business that cornered the market for managing drug company clinical trials, in the middle of a pandemic. That’s part of the story of IQVIA IQV IMS Health |
| 06.10.2020 | What doubts? New forecast says biosimilars will cut U.S. drug spending by $100 billion in five years | After a period of protracted uncertainty, a new report asserts the long-awaited market for biosimilars appears to be taking off in the U.S. and is on track to reduce overall spending on medicines by $100 billion over the next five years.
So... |
| 01.10.2020 | Care At The Counter: Technology And Policy Are Empowering Pharmacists | According to the Association of American Medical Colleges (AAMC), the U.S. is staring down the barrel of a primary care physician (PCP) shortage to the tune of 21,000 to 55,000 primary care providers (PCPs) by 2023. This is worrisome on its... |
| 21.09.2020 | How Covid-19 is driving regional innovation in digital health | Since the start of the Covid-19 pandemic, millions of people in every corner of the world have been touched by human tragedy and financial hardship from the global economic downturn. As difficult as these hardships have been, coping with Co... |
| 14.09.2020 | Say No To Importing Foreign Price Controls On Drugs | President Trump holds up a signed executive order on lowering drug prices on July 24.ASSOCIATED PRESS |
| 04.08.2020 | Prescription drugs may be more affordable than you think — unless you pay cash | Amid growing complaints that many Americans cannot afford their prescription medicines, most people in the U.S. who have insurance are paying lower out-of-pocket costs, but cash-paying customers are shelling out significantly more than five... |
| 02.07.2020 | The Next Challenge: Preventing Over 50,000 Unnecessary Cancer Deaths | Chief Product Officer at Digital Reasoning, creating the future of human-computer interaction. |
| 02.06.2020 | It’s time to bring generic drug manufacturing back to the U.S. | In a hearing Tuesday afternoon on Capitol Hill, policymakers will consider repatriating America’s drug supply chain to avoid future shortages like the ones caused by Covid-19. They should think bigger.
Repatriating the American drug supply ... |
| 20.04.2020 | Value-Based Care’s Story Will Turn in the 2020s | Daniel Kus, VP of Pharmacy Services at Henry Ford Health System Troy Polan, acting CEO of ExceleraRx Corp
Value-based care initiatives matured in recent years thanks to exciting new technology and influential policy changes. But the coming ... |
| 01.04.2020 | Biosimilars could disappear if the Supreme Court overturns the ACA | With the sense of urgency rightly focused on slowing or stopping the spread of Covid-19, it seems like everything else in the news, and in health care, has come to a grinding halt. Yet important decision-making continues in the background, ... |
| 05.03.2020 | Coronavirus spending: an expense — or an investment? | In the context of a looming global pandemic, what does it mean to invest in public health?
At a White House meeting this week, President Donald Trump convened key biopharmaceutical industry leaders to advance the development of effective tr... |
| 28.02.2020 | Reltio Ranks Among Top 3 Percent of Companies on the inaugural 2020 Inc. 5000 Series | “It’s an honor to be included among the Inc. 5000 Series of fastest-growing private companies in California after being named to the national list for the last three years running,” said Manish Sood, CEO of Reltio. “Reltio helps innovative ... |
